{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:19:02Z","timestamp":1789503542011,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.ijcard.2015.07.038","type":"journal-article","created":{"date-parts":[[2015,9,21]],"date-time":"2015-09-21T18:46:59Z","timestamp":1442861219000},"page":"15-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction (HFpEF)"],"prefix":"10.1016","volume":"200","author":[{"given":"Annalisa","family":"Capuano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Scavone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liberata","family":"Sportiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe M.C.","family":"Rosano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J. Stewart","family":"Coats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2015.07.038_bb0005","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.07.038_bb0010","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s12170-011-0184-2","article-title":"Heart failure with preserved ejection fraction: persistent diagnosis, therapeutic enigma","volume":"5","author":"Taslima","year":"2011","journal-title":"Curr. Cardiovasc. Risk Rep."},{"key":"10.1016\/j.ijcard.2015.07.038_bb0015","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1253\/circj.CJ-15-0368","article-title":"Current challenges in the management of heart failure","volume":"79","author":"Komajda","year":"2015","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2015.07.038_bb0020","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.07.038_bb0025","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.07.038_bb0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.07.038_bb0035","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.cardfail.2011.04.007","article-title":"Results of the randomized aldosterone antagonism in heart failure with preserved ejection fraction trial (RAAM-PEF)","volume":"17","author":"Deswal","year":"2011","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2015.07.038_bb0040","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.amjcard.2012.05.049","article-title":"Usefulness of matrix metalloproteinase-9 plasma levels to identify patients with preserved left ventricular systolic function after acute myocardial infarction who could benefit from eplerenone","volume":"110","author":"Kampourides","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.07.038_bb0045","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jama.2013.905","article-title":"Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial","volume":"309","author":"Edelmann","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2015.07.038_bb0050","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.07.038_bb0055","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.cardfail.2014.05.010","article-title":"Effects of spironolactone treatment in elderly women with heart failure and preserved left ventricular ejection fraction","volume":"20","author":"Kurrelmeyer","year":"2014","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2015.07.038_bb0060","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jchf.2012.08.001","article-title":"Aldosterone antagonists and outcomes in real-world older patients with heart failure and preserved ejection fraction","volume":"1","author":"Patel","year":"2013","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.ijcard.2015.07.038_bb0065","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/ejhf.203","article-title":"Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trial","volume":"17","author":"Edelmann","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2015.07.038_bb0070","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/jhh.2014.83","article-title":"Effect of spironolactone on diastolic function in hypertensive left ventricular hypertrophy","volume":"29","author":"Gupta","year":"2015","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.ijcard.2015.07.038_bb0075","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/ejhf.137","article-title":"Association between cardiovascular vs. non-cardiovascular co-morbidities and outcomes in heart failure with preserved ejection fraction","volume":"16","author":"Lund","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2015.07.038_bb0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejim.2004.10.007","article-title":"The aldosterone antagonist and facultative diuretic eplerenone: a critical review","volume":"16","author":"Reyes","year":"2005","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.ijcard.2015.07.038_bb0085","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.amjcard.2014.03.017","article-title":"Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions","volume":"113","author":"Bavishi","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.07.038_bb0090","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/HJH.0b013e3283455ca5","article-title":"A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism","volume":"29","author":"Parthasarathy","year":"2011","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ijcard.2015.07.038_bb0095","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/phar.1556","article-title":"Pharmacotherapy of heart failure with preserved ejection fraction","volume":"35","author":"Basaraba","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijcard.2015.07.038_bb0100","doi-asserted-by":"crossref","first-page":"108","DOI":"10.17987\/icfj.v1i3.33","article-title":"The management of heart failure with preserved ejection fraction (HFpEF)","volume":"1","author":"Stewart Coats","year":"2014","journal-title":"Int. Cardiovasc. Forum J."},{"key":"10.1016\/j.ijcard.2015.07.038_bb0105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijcard.2014.02.018","article-title":"In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry","volume":"173","author":"Senni","year":"2014","journal-title":"Int. J. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315013704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315013704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T03:57:14Z","timestamp":1537329434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527315013704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":21,"alternative-id":["S0167527315013704"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.07.038","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction (HFpEF)","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.07.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}